Doç. Dr. Ahmet Özveren

Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study

Cancers, 2026

DOI 10.3390/cancers18121979 PMID 42352512 Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

Cancers, 2026

DOI 10.3390/cancers18142302 PMID 42512369 Frei zugänglicher VolltextQuelle: ORCID

Impact of oral nutritional support adherence on muscle strength, body composition, and general health status in gastrointestinal cancer patients: ONMUS study

Nutrition, 2026

DOI 10.1016/j.nut.2025.113029 PMID 41455457 1 Zitation (Europe PMC) Quelle: ORCID

Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group

International Journal of Cancer, 2025

DOI 10.1002/ijc.70213 PMID 41147655 3 Zitationen (Europe PMC) Quelle: OpenAlex

Real-world comparison of doxorubicin–ifosfamide versus gemcitabine–docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study

Discover Oncology, 2025

DOI 10.1007/s12672-025-03886-1 PMID 41249604 Frei zugänglicher VolltextQuelle: OpenAlex

Impact of Treatment Duration in First-Line Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Multicenter Real-World Retrospective Study

Medicina, 2025

DOI 10.3390/medicina61071230 PMID 40731859 Frei zugänglicher VolltextQuelle: OpenAlex

Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study

Cancers, 2024

DOI 10.3390/cancers17010046 PMID 39796675 9 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study

Scientific Reports, 2024

DOI 10.1038/s41598-024-75293-5 PMID 39384975 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Alterations in muscle strength among patients with GI cancers receiving oral nutritional support as soon as malnutrition was detected: ONMUS study.

Journal of Clinical Oncology, 2024

DOI 10.1200/jco.2024.42.3_suppl.741 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Is there a role for cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from unusual types of cancer?

European Journal of Surgical Oncology, 2024

DOI 10.1016/j.ejso.2023.107866 Quelle: OpenAlex

Effect of Radiologically Evaluated Sarcopenia on Survival in Advanced Pancreatic Cancer

The Anatolian Journal of General Medical Research, 2024

DOI 10.4274/anatoljmed.2023.16432 Frei zugänglicher VolltextQuelle: OpenAlex

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study

Journal of Cancer Research and Clinical Oncology, 2023

DOI 10.1007/s00432-023-04766-3 PMID 37067546 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

The inflammatory prognostic index as a potential predictor of prognosis in metastatic gastric cancer

Scientific Reports, 2023

DOI 10.1038/s41598-023-34778-5 PMID 37173358 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Real-Life Data of Neoadjuvant Chemotherapy in Breast Cancer: Aegean Region Experience

European Journal of Therapeutics, 2023

DOI 10.58600/eurjther.20232902-347.y Frei zugänglicher VolltextQuelle: ORCID

The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer

Integrative Cancer Therapies, 2023

DOI 10.1177/15347354231165938 PMID 36987394 Frei zugänglicher VolltextQuelle: ORCID

Second-Line Chemotherapy in Gastric Cancer: a Retrospective Study

Indian Journal of Surgical Oncology, 2023

DOI 10.1007/s13193-022-01695-4 PMID 37324318 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Chemotherapy Choice in Neoadjuvant Dual Her2 Blockade: Is it Really Essential to Add Anthracycline?

Eurasian Journal of Medical Investigation, 2023

DOI 10.14744/ejmi.2023.59897 Quelle: OpenAlex

The Effect of the Modified Glasgow Prognostic Score and Neutrophil/Lymphocyte Ratio on Prognosis in Stage 4 Pancreatic Cancer

Eurasian Journal of Medical Investigation, 2023

DOI 10.14744/ejmi.2023.79007 Quelle: OpenAlex

The effect of the modified Glasgow prognostic score in metastatic gastric cancer

SVU-International Journal of Medical Sciences, 2023

DOI 10.21608/svuijm.2023.201018.1554 Frei zugänglicher VolltextQuelle: OpenAlex

Current Topics In Hemato-Oncology

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1576 Frei zugänglicher VolltextQuelle: ORCID

Systemic Immune Inflammation Index as a Key Marker of Survival and Immune-related Adverse Events in Immune Checkpoint Inhibitor Therapy.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2022

DOI 10.29271/jcpsp.2022.08.996 PMID 35932122 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Chemotherapy Choice in Neoadjuvant Dual Her2 Blockade; Is It Really Necessary to Add Anthracycline?

Research Square, 2022

DOI 10.21203/rs.3.rs-531944/v2 Frei zugänglicher VolltextQuelle: ORCID

The Inflammatory Prognostic Index; A Potential Predictor In Stage-4 Gastric Cancer

2022

DOI 10.21203/rs.3.rs-1264323/v1 Frei zugänglicher VolltextQuelle: ORCID

Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost?

Journal of Gastrointestinal Cancer, 2022

DOI 10.1007/s12029-020-00573-y PMID 33400209 1 Zitation (Europe PMC) Quelle: ORCID

Palliative Biliary Drainage Has No Effect on Survival in Pancreatic Cancer: Medical Oncology Perspective

Journal of Gastrointestinal Cancer, 2022

DOI 10.1007/s12029-021-00754-3 PMID 34767180 1 Zitation (Europe PMC) Quelle: ORCID

The Inflammatory Prognostic Index; A Potential Predictor In Stage-4 Gastric Cancer

ResearchSquare, 2022

DOI 10.21203/rs.3.rs-1264323 Quelle: ORCID

Sarkomlar ve Cilt Tümörleri

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1097 Frei zugänglicher VolltextQuelle: OpenAlex

Hepatosellüler Karsinomda Klinik ve Prognostik Özelliklerin Değerlendirilmesi: Tek Merkez Deneyimi

Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 2021

DOI 10.34087/cbusbed.830940 Frei zugänglicher VolltextQuelle: ORCID

Chemotherapy Choice in Neoadjuvant Dual Her2 Blockade; is it Really Necessary to add Anthracycline?

Research Square, 2021

DOI 10.21203/rs.3.rs-531944/v1 Frei zugänglicher VolltextQuelle: ORCID

Are Hormonal Agents Better Than Chemo İn Metastati̇c Castrati̇on Resistant Prostate Cancer?

2021

DOI 10.21203/rs.3.rs-199255/v1 Frei zugänglicher VolltextQuelle: ORCID

Pancreatic cancer patients who cannot undergo curative surgery live as much as patients over 70 years old.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2021

DOI 10.21203/rs.3.rs-150867/v1 PMID 34565025 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Evaluation of sarcopenia, sarcopenic obesity, and phase angle in geriatric gastrointestinal cancer patients: before and after chemotherapy

Turkish journal of medical sciences, 2019

DOI 10.3906/sag-1808-114 PMID 30997793 17 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Biweekly cetuximab in combination with platinum and 5-fluorouracil in metastatic head and neck carcinoma

Indian Journal of Cancer, 2019

DOI 10.4103/ijc.ijc_355_18 PMID 30950435 1 Zitation (Europe PMC) Quelle: ORCID

The effect of chemotherapy on nutritional status and weakness in geriatric gastrointestinal system cancer patients

Nutrition, 2018

DOI 10.1016/j.nut.2017.09.013 PMID 29429533 19 Zitationen (Europe PMC) Quelle: ORCID

SUN-P078: Determination of Malnutrition and Sarcopenia in Geriatric Patients with Gastrointestinal Malignancy

Clinical Nutrition, 2016

DOI 10.1016/s0261-5614(16)30421-6 Quelle: OpenAlex

Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines

Cancer Chemotherapy and Pharmacology, 2015

DOI 10.1007/s00280-015-2756-1 PMID 25925002 12 Zitationen (Europe PMC) Quelle: ORCID

Prognostic effect of tumor location in stage II and III colon cancer

Journal of Clinical Oncology, 2015

DOI 10.1200/jco.2015.33.15_suppl.e14652 Quelle: ORCID

Prognostic role of neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with docetaxel

Journal of Clinical Oncology, 2015

DOI 10.1200/jco.2015.33.15_suppl.e16050 2 Zitationen (OpenAlex) Quelle: ORCID

SUN-PP124: Correlation between Mini Nutritional Assessment and Hand Grip Strength in Geriatric Patients with Gastrointestinal Cancer

Clinical Nutrition, 2015

DOI 10.1016/s0261-5614(15)30275-2 Quelle: OpenAlex

A Case of Crescentic Glomerulonephritis That Developed After Marijuana Use

Turkiye Klinikleri Journal of Nephrology, 2014

Quelle: OpenAlex

A puzzling case of phospho-soda-induced hypocalcemia in a patient with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism

Internal Medicine, 2012

DOI 10.2169/internalmedicine.51.7475 PMID 23154721 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Mortality In Geriatric Patients With Upper Gastrointestinal Bleeding

The Anatolian Journal of General Medical Research, 2012

DOI 10.5222/terh.2012.73466 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex